Antidiabetics Except Insulin | Biguanides | Sulfonylureas | Thiazolidinediones | DPP-4 Inhibitor | GLP-1 Analogue | alpha-Glucosidase Inhibitors | Meglitinide | Combined Modality Therapy
Item
patients with a first-ever prescription for a non-insulin anti-diabetic drug, including biguanides, sulfonylureas, thiazolidinediones, dpp-4 inhibitors, glp-1 analogs, alpha-glucosidase inhibitors, meglitinides or combinations of these drugs from the earliest availability of data at each site to the last date of availability of data.
boolean
C0935929 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0021641 (UMLS CUI [1,3])
C0005382 (UMLS CUI [2])
C0038766 (UMLS CUI [3])
C1257987 (UMLS CUI [4])
C3537225 (UMLS CUI [5])
C3273809 (UMLS CUI [6])
C1299007 (UMLS CUI [7])
C0065880 (UMLS CUI [8])
C0009429 (UMLS CUI [9])
Medical History Database Duration
Item
patients with at least 1 year of history in the database.
boolean
C0262926 (UMLS CUI [1,1])
C0242356 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Age
Item
patients at least 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Patient Outcome - Died | Cohort Withdrawal by Subject
Item
patients who died or left the cohort before the year the first incretin-based drug entered the market.
boolean
C1546956 (UMLS CUI [1])
C0599755 (UMLS CUI [2,1])
C1710677 (UMLS CUI [2,2])
Absence Antidiabetics Additional | Absence Antidiabetics Change
Item
patients who never added-on or switched to a new anti-diabetic drug after incretin-based drugs entered the market up until june 30, 2014.
boolean
C0332197 (UMLS CUI [1,1])
C0935929 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C0935929 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
Pancreatic carcinoma | Pancreatectomy | Congenital defects Pancreas | Cystic Fibrosis | Lupus Erythematosus | Bariatric Surgery
Item
patients with a previous diagnosis of pancreatic cancer, those who underwent pancreatectomy, those with diagnoses of congenital defects of the pancreas, cystic fibrosis, lupus, or previous bariatric surgery, at any time prior to study cohort entry.
boolean
C0235974 (UMLS CUI [1])
C0030279 (UMLS CUI [2])
C0000768 (UMLS CUI [3,1])
C0030274 (UMLS CUI [3,2])
C0010674 (UMLS CUI [4])
C0409974 (UMLS CUI [5])
C1456587 (UMLS CUI [6])
HIV Infection | HAART
Item
patients diagnosed with hiv or initiating haart therapy before and at study cohort entry.
boolean
C0019693 (UMLS CUI [1])
C0887947 (UMLS CUI [2])
Hospitalization Pancreatitis
Item
patients hospitalized for acute pancreatitis in the 30 days before study cohort entry.
boolean
C0019993 (UMLS CUI [1,1])
C0030305 (UMLS CUI [1,2])